A456070 logo

ENCell Co., Ltd. Stock Price

KOSDAQ:A456070 Community·₩182.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A456070 Share Price Performance

₩16,700.00
-4550.00 (-21.41%)
₩16,700.00
-4550.00 (-21.41%)
Price ₩16,700.00

A456070 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with low risk.

3 Risks
0 Rewards

ENCell Co., Ltd. Key Details

₩5.9b

Revenue

₩8.9b

Cost of Revenue

-₩3.0b

Gross Profit

₩14.8b

Other Expenses

-₩17.8b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-1.63k
-50.42%
-300.86%
1.7%
View Full Analysis

About A456070

Founded
2018
Employees
n/a
CEO
n/a
WebsiteView website
encellinc.com

ENCell Co., Ltd. develops cell/gene-based biopharmaceutical products in South Korea. The company develops EN00, an allogeneic umbilical cord-derived mesenchymal stem cell treatment for Charcot-Marie-Tooth disease It also provides contracting development and manufacturing services for biopharmaceutical products. The company was founded in 2018 and is based in Seoul, South Korea.

Recent A456070 News & Updates

Recent updates

No updates